PEDIATRICS Vol. 26 No. 2 August 1960, pp. 285-292
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naylor, J.
Right arrow Articles by Hsia, D. Y.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naylor, J.
Right arrow Articles by Hsia, D. Y.-Y.

ACTIVITY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE IN ERYTHROCYTES OF PATIENTS WITH VARIOUS ABNORMAL HEMOGLOBINS

Jean Naylor M.D.1, Ira Rosenthal M.D.1, Aaron Grossman M.D.1, Irving Schulman M.D.1, and David Yi-Yung Hsia M.D.1

1 Departments of Pediatrics, Northwestern University Medical School, University of Illinois Medical School, and Chicago Medical School; the Children's Memorial Hospital, the University of Illinois Research and Education Hospital, and the Children's Division of the Cook County Hospital, Chicago

In 99 patients with sickle cell anemia and 100 normal Negro children, the activity of glucose-6-phosphate dehydrogenase in erythrocytes was determined.

Hemoglobinopathies may be combined with reduced activity of glucose-6-phosphate dehydrogenase in the erythrocytes.

The two defects are inherited independently.

The incidence of the enzymatic defect in the erythrocytes of those with sickle cell anemia in this series does not differ from that of a similar Negro population having normal hemoglobin.

There appears to be no significant effect of the enzymatic defect in the erythrocytes on the clinical course of patients with sickle cell anemia or survival times of their erythrocytes.

Patients with sickle cell anemia and with normal stability of the glutathione in the erythrocytes have significantly higher levels of G6PD than controls or patients with sickle cell trait.